The data displays revenues of the United States biotech industry - composed only of public biotech companies from 2012 to 2014, listed by geographical area (metropolitan region). In New England, revenues of such companies came to almost 11.3 billion USD in 2012.
San Francisco Bay Area | 15096 | 16777 | 32610 |
Los Angeles/Orange County | 17326 | 18972 | 20335 |
New England | 11283 | 12993 | 16517 |
New Jersey | 6329 | 7506 | 8971 |
New York State | 2075 | 2831 | 3706 |
San Diego | 5708 | 6117 | 2870 |
Mid-Atlantic | 1480 | 1723 | 2277 |
North Carolina | 862 | 972 | 1247 |
Pennsylvania/Delaware Valley | 1140 | 1194 | 899 |
Utah | 496 | 613 | 778 |
Pacific Northwest | 608 | 660 | 537 |
Southeast | 206 | 266 | 335 |
Texas | 226 | 260 | 254 |
Midwest | 39 | 111 | 67 |
Colorado | 85 | 70 | 62 |
Other | 776 | 848 | 1585 |